Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin light chain 5 (MYL5) is a phosphorylatable regulatory light chain of the hexameric ATPase cellular motor protein myosin. It is involved in the regulation of myosin function, important for muscle contraction and actin cytoskeleton-dependent processes. MYL5 localizes to mitotic spindle poles and is necessary for proper cell division, contributing to spindle assembly, chromosome congression, and segregation. It binds calcium and contains EF-hand domains, and is expressed in fetal muscle, adult retina, cerebellum, and basal ganglia. MYL5 variants have been implicated in Limb-Girdle Muscular Dystrophy and are being investigated as a possible prognostic marker in breast cancer
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin light chain 5 (MYL5).